EZH1 in germ cells safeguards the function of PRC2 during spermatogenesis

被引:33
|
作者
Mu, Weipeng
Starmer, Joshua
Shibata, Yoichiro
Yee, Della
Magnuson, Terry [1 ]
机构
[1] Univ North Carolina Chapel Hill, Dept Genet, Chapel Hill, NC 27599 USA
基金
美国国家卫生研究院;
关键词
EZH1; EZH2; Polycomb-Group protein; Histone methylation; Enhancer; Spermatogenesis; STEM-CELLS; TRANSCRIPTION FACTOR; GENE-EXPRESSION; MALE MEIOSIS; POLYCOMB; COMPLEX; METHYLATION; DIFFERENTIATION; CHROMATIN; ENHANCER;
D O I
10.1016/j.ydbio.2017.02.017
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
We previously reported the requirement of Polycomb Repressive Complex 2 (PRC2) for spermatogenesis through transcriptional repression of somatic genes and meiosis-specific genes. To characterize how PRC2's two methyltransferase subunits, EZH1 and EZH2, regulate histone H3 lysine 27 (H3K27) methylation during germ. cell development, we generated mouse models with a germline ablation of EZH1 and/or EHZ2. Only the combined loss of EZH1 and EZH2 caused a depletion of global H3K27me3 marks and meiotic arrest in spermatocytes. Genome-wide analysis of H3K27me3 in spermatogenic cells revealed that a noncanonical EZH1-PRC2 could establish and maintain this histone mark on somatic genes and certain meiotic genes. Consistent with it having active enhancers in testis, Ezh1 was not only abundant in highly differentiated spermatocytes but also in actively proliferating progenitor and stem germ cells. Taken together, our findings suggest that the expression level of Ezhl determines the restoration of H3K27 methylation in the absence of the canonical EZH2-PRC2.
引用
收藏
页码:198 / 207
页数:10
相关论文
共 50 条
  • [21] PRC1 sustains the integrity of neural fate in the absence of PRC2 function
    Sawai, Ayana
    Pfennig, Sarah
    Bulajic, Milica
    Miller, Alexander
    Khodadadi-Jamayran, Alireza
    Mazzoni, Esteban O.
    Dasen, Jeremy S.
    ELIFE, 2022, 11
  • [22] Misregulation Of The PRC2 Complex In CML Stem Cells Confers Sensitivity To An EZH2 Inhibitor
    Scott, Mary T.
    Korfi, Koorosh
    Gallipoli, Paolo
    Saffrey, Peter
    Jorgensen, Heather
    Cruz, Michelle
    Hamilton, Ashley
    Sinclair, Amy
    Crossan, Andrew
    Normant, Emmanuel
    Balasubramanian, Vidya
    Holyoake, Tessa L.
    Vetrie, David
    BLOOD, 2013, 122 (21)
  • [23] Targeting EZH2 and PRC2 dependence as novel anticancer therapy
    Xu, Bowen
    Konze, Kyle D.
    Jin, Jian
    Wang, Gang Greg
    EXPERIMENTAL HEMATOLOGY, 2015, 43 (08) : 698 - 712
  • [24] COOLAIR and PRC2 function in parallel to silence FLC during vernalization
    Nielsen, Mathias
    Menon, Govind
    Zhao, Yusheng
    Bonmati, Eduardo Mateo -
    Wolff, Philip
    Zhou, Shaoli
    Howard, Martin
    Dean, Caroline
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2024, 121 (04)
  • [25] PRC1 and PRC2 proximal interactome in mouse embryonic stem cells
    Zijlmans, Authors Dick W.
    Stelloo, Suzan
    Bax, Danique
    Yordanov, Yavor
    Toebosch, Pien
    Raas, Maximilian W. D.
    Verhelst, Sigrid
    Lamers, Lieke A.
    Baltissen, Marijke P. A.
    Jansen, Pascal W. T. C.
    van Mierlo, Guido
    Dhaenens, Maarten
    Marks, Hendrik
    Vermeulen, Michiel
    CELL REPORTS, 2025, 44 (03):
  • [26] Recruitment of PRC1 function at the initiation of X inactivation independent of PRC2 and silencing
    Schoeftner, Stefan
    Sengupta, Aditya K.
    Kubicek, Stefan
    Mechtler, Karl
    Spahn, Laura
    Koseki, Haruhiko
    Jenuwein, Thomas
    Wutz, Anton
    EMBO JOURNAL, 2006, 25 (13): : 3110 - 3122
  • [27] The role of EZH1 and EZH2 in development and cancer
    Lee, Soo Hyun
    Li, Yingying
    Kim, Hanbyeol
    Eum, Seounghyun
    Park, Kyumin
    Lee, Chul-Hwan
    BMB REPORTS, 2022, 55 (12) : 595 - 601
  • [28] Interplay of Fra-2/AP-1 and Ezh2/PRC2 orchestrates epidermal differentiation
    Wurm, Stefanie
    Guinea-Viniegra, Juan
    Zhang, Jisheng
    Ezhkova, Elena
    Wagner, Erwin Friedrich
    CANCER RESEARCH, 2014, 74 (19)
  • [29] EZH1/2 as targets for cancer therapy
    Ran An
    Yu-Qing Li
    Yue-Ling Lin
    Fang Xu
    Man-Mei Li
    Zhong Liu
    Cancer Gene Therapy, 2023, 30 : 221 - 235
  • [30] Engaging chromatin: PRC2 structure meets function
    Paul Chammas
    Ivano Mocavini
    Luciano Di Croce
    British Journal of Cancer, 2020, 122 : 315 - 328